Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asato Hashinokuchi

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Surgery Today|May 1, 2024
Maximum resistance pressure at the time of lung tissue rupture after porcine lung transection using automatic linear staplers with different reinforcement methodsShinkichi Takamori, Tomoyoshi Takenaka, Mototsugu Shimokawa, et al.
Translational Cancer Research|March 14, 2023
Conservative treatment for residual lung congestion after left upper trisegmentectomy: a case reportTaichi Nagano, Naoki Haratake, Kyoto Matsudo, et al.
Anticancer Research|November 1, 2023
Impact of Chronic Obstructive Pulmonary Disease on the Long-term Prognosis of Patients Undergoing Lobectomy for Non-small-cell Lung Cancer: A Propensity Score-matched AnalysisKyoto Matsudo, Tomoyoshi Takenaka, Asato Hashinokuchi, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 11, 2024
Assessment of the Therapeutic Potential of Enhancer of Zeste Homolog 2 Inhibition in a Murine Model of Bronchiolitis Obliterans SyndromeKyoto Matsudo, Shinkichi Takamori, Tomoyoshi Takenaka, et al.
The Annals of Thoracic Surgery|June 20, 2024
CD155 Expression in Early-Stage Lung AdenocarcinomaKyoto Matsudo, Kazuki Takada, Fumihiko Kinoshita, et al.
Chest|July 14, 2024
Role of Pathologic Single-Nodal and Multiple-Nodal Descriptors in Resected Non-Small Cell Lung CancerShinkichi Takamori, Atsushi Osoegawa, Asato Hashinokuchi, et al.
Annals of Surgical Oncology|January 15, 2025
Significance of Tumor Microvasculature in the Tumor Microenvironment in Adenocarcinoma with EGFR Common MutationsKyoto Matsudo, Kazuki Takada, Asato Hashinokuchi, et al.
International Journal of Clinical Oncology|October 23, 2024
Clinical significance of CD155 expression in surgically resected lung squamous cell carcinomaTaichi Nagano, Kazuki Takada, Asato Hashinokuchi, et al.
International Journal of Clinical Oncology|April 27, 2025
CD155 expression and co-expression with PD-L1 are not associated with poor prognosis in patients with stage II and III lung adenocarcinoma undergoing surgical resectionKyoto Matsudo, Kazuki Takada, Asato Hashinokuchi, et al.
Annals of Surgical Oncology|February 27, 2023
Prognostic Impact of C-Reactive Protein-to-Lymphocyte Ratio in Non-small Cell Lung Cancer: A Propensity Score-Matching AnalysisTaichi Nagano, Fumihiko Kinoshita, Asato Hashinokuchi, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Surgery Today|May 1, 2024
Maximum resistance pressure at the time of lung tissue rupture after porcine lung transection using automatic linear staplers with different reinforcement methodsShinkichi Takamori, Tomoyoshi Takenaka, Mototsugu Shimokawa, et al.
Translational Cancer Research|March 14, 2023
Conservative treatment for residual lung congestion after left upper trisegmentectomy: a case reportTaichi Nagano, Naoki Haratake, Kyoto Matsudo, et al.
Anticancer Research|November 1, 2023
Impact of Chronic Obstructive Pulmonary Disease on the Long-term Prognosis of Patients Undergoing Lobectomy for Non-small-cell Lung Cancer: A Propensity Score-matched AnalysisKyoto Matsudo, Tomoyoshi Takenaka, Asato Hashinokuchi, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 11, 2024
Assessment of the Therapeutic Potential of Enhancer of Zeste Homolog 2 Inhibition in a Murine Model of Bronchiolitis Obliterans SyndromeKyoto Matsudo, Shinkichi Takamori, Tomoyoshi Takenaka, et al.
The Annals of Thoracic Surgery|June 20, 2024
CD155 Expression in Early-Stage Lung AdenocarcinomaKyoto Matsudo, Kazuki Takada, Fumihiko Kinoshita, et al.
Chest|July 14, 2024
Role of Pathologic Single-Nodal and Multiple-Nodal Descriptors in Resected Non-Small Cell Lung CancerShinkichi Takamori, Atsushi Osoegawa, Asato Hashinokuchi, et al.
Annals of Surgical Oncology|January 15, 2025
Significance of Tumor Microvasculature in the Tumor Microenvironment in Adenocarcinoma with EGFR Common MutationsKyoto Matsudo, Kazuki Takada, Asato Hashinokuchi, et al.
International Journal of Clinical Oncology|October 23, 2024
Clinical significance of CD155 expression in surgically resected lung squamous cell carcinomaTaichi Nagano, Kazuki Takada, Asato Hashinokuchi, et al.
International Journal of Clinical Oncology|April 27, 2025
CD155 expression and co-expression with PD-L1 are not associated with poor prognosis in patients with stage II and III lung adenocarcinoma undergoing surgical resectionKyoto Matsudo, Kazuki Takada, Asato Hashinokuchi, et al.
Annals of Surgical Oncology|February 27, 2023
Prognostic Impact of C-Reactive Protein-to-Lymphocyte Ratio in Non-small Cell Lung Cancer: A Propensity Score-Matching AnalysisTaichi Nagano, Fumihiko Kinoshita, Asato Hashinokuchi, et al.
Pageof 4